The article highlights claims alleging defective cannula manufacturing that led to insulin under-delivery in millions of Omnipod devices. While no settlement, recall outcome, or financial figures are provided, the allegation raises product-safety and legal overhang risk for the company.
The article highlights claims alleging defective cannula manufacturing that led to insulin under-delivery in millions of Omnipod devices. While no settlement, recall outcome, or financial figures are provided, the allegation raises product-safety and legal overhang risk for the company.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
mildly negative
Sentiment Score
-0.35
